FOLH1 and prostate carcinoma: Employment of another PSMA-positive prostate cancer cell line (CWR22Rv1) through western blot analysis (Fig. 5) further validated that CWR22Rv1-derived exosomes were also enriched with highly glycosylated PSMA analogous to LNCaP-derived exosomes.